Latest Insider Transactions at Integer Holdings Corp (ITGR)
This section provides a real-time view of insider transactions for Integer Holdings Corp (ITGR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Integer Holdings Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Integer Holdings Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Jason K Garland EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
533
-5.27%
|
$45,305
$85.59 P/Share
|
|
Dec 31
2021
|
Jason K Garland EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,183
+10.27%
|
-
|
|
Dec 31
2021
|
Anthony W Borowicz SVP Strategy,Corp Dev., IR |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-1.15%
|
$21,420
$85.59 P/Share
|
|
Dec 31
2021
|
Anthony W Borowicz SVP Strategy,Corp Dev., IR |
BUY
Exercise of conversion of derivative security
|
Direct |
658
+1.48%
|
-
|
|
Dec 07
2021
|
Jean M. Hobby Director |
SELL
Open market or private sale
|
Direct |
1,200
-9.56%
|
$102,000
$85.38 P/Share
|
|
Dec 06
2021
|
Pamela G Bailey Director |
SELL
Open market or private sale
|
Direct |
7,231
-6.39%
|
$607,404
$84.79 P/Share
|
|
Dec 06
2021
|
Pamela G Bailey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,231
+11.3%
|
$144,620
$20.62 P/Share
|
|
Oct 02
2021
|
Jason K Garland EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
607
-7.11%
|
$55,844
$92.12 P/Share
|
|
Oct 02
2021
|
Jason K Garland EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,490
+22.58%
|
-
|
|
Sep 14
2021
|
Joseph F Flanagan EVP, Quality & Regulatory Affa |
SELL
Open market or private sale
|
Direct |
2,645
-20.99%
|
$245,985
$93.13 P/Share
|
|
Aug 20
2021
|
Bill R Sanford Director |
SELL
Open market or private sale
|
Direct |
10,527
-10.33%
|
$1,010,592
$96.9 P/Share
|
|
Aug 20
2021
|
Bill R Sanford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,527
+16.99%
|
$221,067
$21.35 P/Share
|
|
Aug 15
2021
|
Elizabeth Giddens SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
140
-11.2%
|
$12,740
$91.83 P/Share
|
|
Aug 15
2021
|
Elizabeth Giddens SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
572
+31.39%
|
-
|
|
Aug 11
2021
|
Anthony W Borowicz SVP Strategy,Corp Dev., IR |
SELL
Open market or private sale
|
Direct |
1,100
-4.9%
|
$99,000
$90.22 P/Share
|
|
Aug 04
2021
|
Carter Houghton President, Electrochem |
SELL
Open market or private sale
|
Direct |
2,500
-48.0%
|
$232,500
$93.55 P/Share
|
|
Jun 15
2021
|
Bill R Sanford Director |
SELL
Open market or private sale
|
Direct |
10,846
-20.96%
|
$986,986
$91.25 P/Share
|
|
Jun 15
2021
|
Bill R Sanford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,846
+17.33%
|
$216,920
$20.62 P/Share
|
|
May 19
2021
|
Jean M. Hobby Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,820
+12.66%
|
-
|
|
May 19
2021
|
Cheryl C Capps Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,820
+41.32%
|
-
|
|
May 19
2021
|
Filippo Passerini Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,820
+11.05%
|
-
|
|
May 19
2021
|
Sheila Antrum Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,820
+41.32%
|
-
|
|
May 19
2021
|
Alvin Tyrone Jeffers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,820
+41.32%
|
-
|
|
May 19
2021
|
Martin C Maxwell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,820
+8.6%
|
-
|
|
May 13
2021
|
Carter Houghton President, Electrochem |
SELL
Payment of exercise price or tax liability
|
Direct |
772
-12.91%
|
$71,024
$92.24 P/Share
|
|
May 13
2021
|
Carter Houghton President, Electrochem |
BUY
Exercise of conversion of derivative security
|
Direct |
3,167
+34.62%
|
-
|
|
Apr 22
2021
|
Joel Becker President, CRM & Neuro |
SELL
Payment of exercise price or tax liability
|
Direct |
124
-9.02%
|
$11,408
$92.82 P/Share
|
|
Apr 22
2021
|
Joel Becker President, CRM & Neuro |
BUY
Exercise of conversion of derivative security
|
Direct |
507
+26.95%
|
-
|
|
Apr 01
2021
|
Jennifer M Bolt EVP, Global Operations & ESG |
SELL
Payment of exercise price or tax liability
|
Direct |
64
-0.28%
|
$5,760
$90.88 P/Share
|
|
Apr 01
2021
|
Jennifer M Bolt EVP, Global Operations & ESG |
BUY
Exercise of conversion of derivative security
|
Direct |
217
+0.95%
|
-
|
|
Mar 12
2021
|
Jean M. Hobby Director |
SELL
Open market or private sale
|
Direct |
2,100
-16.36%
|
$197,400
$94.95 P/Share
|
|
Feb 23
2021
|
Anthony W Borowicz SVP Strategy,Corp Dev., IR |
SELL
Open market or private sale
|
Direct |
1,337
-5.62%
|
$112,308
$84.75 P/Share
|
|
Feb 23
2021
|
Anthony W Borowicz SVP Strategy,Corp Dev., IR |
BUY
Exercise of conversion of derivative security
|
Direct |
1,337
+5.33%
|
$64,176
$48.43 P/Share
|
|
Feb 01
2021
|
Alvin Tyrone Jeffers Director |
BUY
Grant, award, or other acquisition
|
Direct |
765
+50.0%
|
-
|
|
Feb 01
2021
|
Cheryl C Capps Director |
BUY
Grant, award, or other acquisition
|
Direct |
765
+50.0%
|
-
|
|
Feb 01
2021
|
Sheila Antrum Director |
BUY
Grant, award, or other acquisition
|
Direct |
765
+50.0%
|
-
|
|
Jan 21
2021
|
Joseph W Dziedzic President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,018
-8.53%
|
$781,404
$78.9 P/Share
|
|
Jan 21
2021
|
Joseph W Dziedzic President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,722
+17.97%
|
-
|
|
Jan 21
2021
|
Jennifer M Bolt EVP, Global Operations & ESG |
SELL
Payment of exercise price or tax liability
|
Direct |
563
-2.45%
|
$43,914
$78.9 P/Share
|
|
Jan 21
2021
|
Jennifer M Bolt EVP, Global Operations & ESG |
BUY
Grant, award, or other acquisition
|
Direct |
1,816
+7.33%
|
-
|
|
Jan 21
2021
|
Joseph F Flanagan EVP, Quality & Regulatory Affa |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-5.15%
|
$53,352
$78.9 P/Share
|
|
Jan 21
2021
|
Joseph F Flanagan EVP, Quality & Regulatory Affa |
BUY
Grant, award, or other acquisition
|
Direct |
2,253
+14.5%
|
-
|
|
Jan 21
2021
|
Payman Khales President, C&V |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-11.05%
|
$40,326
$78.9 P/Share
|
|
Jan 21
2021
|
Payman Khales President, C&V |
BUY
Grant, award, or other acquisition
|
Direct |
2,062
+30.59%
|
-
|
|
Jan 21
2021
|
Kirk K Thor Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-4.74%
|
$33,150
$78.9 P/Share
|
|
Jan 21
2021
|
Kirk K Thor Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,744
+16.28%
|
-
|
|
Jan 21
2021
|
Anthony W Borowicz SVP Strategy,Corp Dev., IR |
SELL
Payment of exercise price or tax liability
|
Direct |
481
-2.1%
|
$37,518
$78.9 P/Share
|
|
Jan 21
2021
|
Anthony W Borowicz SVP Strategy,Corp Dev., IR |
BUY
Grant, award, or other acquisition
|
Direct |
1,272
+5.26%
|
-
|
|
Jan 01
2021
|
Joseph F Flanagan EVP, Quality & Regulatory Affa |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-3.37%
|
$31,185
$81.19 P/Share
|
|
Jan 01
2021
|
Joseph F Flanagan EVP, Quality & Regulatory Affa |
BUY
Exercise of conversion of derivative security
|
Direct |
1,102
+4.7%
|
-
|